{"transactions":[{"id":2761140,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-02T19:03:50.000Z","date":"2021-04-01","kind":"exercise","acquired":false,"shares":329863,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The option vested in full on October 30, 2020."}],"balance_after":0,"derivative":{"exercise_price":5.26,"expiration_date":"2021-04-30","underlying":"Common Stock","underlying_shares":329863},"source":{"system":"sec-edgar","filing":"0001179110-21-004092","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000117911021004092/edgar.xml","form_type":"4"}},{"id":2761139,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-02T19:03:50.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":17477,"price":188.4458,"value":3293467.2466,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents the weighted average price of transactions ranging from $188.295 to $189.00."}],"balance_after":275793,"source":{"system":"sec-edgar","filing":"0001179110-21-004092","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000117911021004092/edgar.xml","form_type":"4"}},{"id":2761138,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-02T19:03:50.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":98588,"price":187.8532,"value":18520071.2816,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the weighted average price of transactions ranging from $187.30 to $188.29."}],"balance_after":293270,"source":{"system":"sec-edgar","filing":"0001179110-21-004092","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000117911021004092/edgar.xml","form_type":"4"}},{"id":2761137,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-02T19:03:50.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":38977,"price":186.9246,"value":7285760.1342,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average price of transactions ranging from $186.30 to $187.29."}],"balance_after":391858,"source":{"system":"sec-edgar","filing":"0001179110-21-004092","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000117911021004092/edgar.xml","form_type":"4"}},{"id":2761136,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-02T19:03:50.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":24759,"price":185.7962,"value":4600128.1158,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average price of transactions ranging from $185.30 to $186.28."}],"balance_after":430835,"source":{"system":"sec-edgar","filing":"0001179110-21-004092","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000117911021004092/edgar.xml","form_type":"4"}},{"id":2761135,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-02T19:03:50.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":44825,"price":184.6821,"value":8278375.1325,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average price of transactions ranging from $184.29 to $185.28."}],"balance_after":455594,"source":{"system":"sec-edgar","filing":"0001179110-21-004092","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000117911021004092/edgar.xml","form_type":"4"}},{"id":2761134,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-02T19:03:50.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":45089,"price":183.7838,"value":8286627.7582,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average price of transactions ranging from $183.29 to $184.28."}],"balance_after":500419,"source":{"system":"sec-edgar","filing":"0001179110-21-004092","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000117911021004092/edgar.xml","form_type":"4"}},{"id":2761133,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-02T19:03:50.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":60148,"price":182.781,"value":10993911.588,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average price of transactions ranging from $182.29 to $183.28. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 8 to this Form 4."}],"balance_after":545508,"source":{"system":"sec-edgar","filing":"0001179110-21-004092","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000117911021004092/edgar.xml","form_type":"4"}},{"id":2761132,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-02T19:03:50.000Z","date":"2021-04-01","kind":"exercise","acquired":true,"shares":329863,"price":5.26,"value":1735079.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020."}],"balance_after":605656,"source":{"system":"sec-edgar","filing":"0001179110-21-004092","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000117911021004092/edgar.xml","form_type":"4"}},{"id":2813044,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-03-03T22:52:11.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":164931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in full on October 30, 2020."}],"balance_after":329863,"derivative":{"exercise_price":5.26,"expiration_date":"2021-04-30","underlying":"Common Stock","underlying_shares":164931},"source":{"system":"sec-edgar","filing":"0001179110-21-002719","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000117911021002719/edgar.xml","form_type":"4"}},{"id":2813043,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-03T22:52:11.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":164931,"price":226.0576,"value":37283906.0256,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average price of transactions ranging from $221.22 to $229.75. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":275793,"source":{"system":"sec-edgar","filing":"0001179110-21-002719","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000117911021002719/edgar.xml","form_type":"4"}},{"id":2813042,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-03T22:52:11.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":164931,"price":5.26,"value":867537.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020."}],"balance_after":440724,"source":{"system":"sec-edgar","filing":"0001179110-21-002719","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000117911021002719/edgar.xml","form_type":"4"}},{"id":2881685,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-02-03T23:03:31.000Z","date":"2021-02-01","kind":"exercise","acquired":false,"shares":164931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in full on October 30, 2020."}],"balance_after":494794,"derivative":{"exercise_price":5.26,"expiration_date":"2021-04-30","underlying":"Common Stock","underlying_shares":164931},"source":{"system":"sec-edgar","filing":"0001179110-21-001277","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000117911021001277/edgar.xml","form_type":"4"}},{"id":2881684,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-03T23:03:31.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":164931,"price":262.61,"value":43312529.91,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average price of transactions ranging from $257.01 to $266.64. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":275793,"source":{"system":"sec-edgar","filing":"0001179110-21-001277","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000117911021001277/edgar.xml","form_type":"4"}},{"id":2881683,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-03T23:03:31.000Z","date":"2021-02-01","kind":"exercise","acquired":true,"shares":164931,"price":5.26,"value":867537.06,"ownership":{"direct":true},"balance_after":440724,"source":{"system":"sec-edgar","filing":"0001179110-21-001277","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000117911021001277/edgar.xml","form_type":"4"}},{"id":2904279,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-01-19T21:04:33.000Z","date":"2021-01-14","kind":"exercise","acquired":false,"shares":164931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in full on October 30, 2020."}],"balance_after":659725,"derivative":{"exercise_price":5.26,"expiration_date":"2021-04-30","underlying":"Common Stock","underlying_shares":164931},"source":{"system":"sec-edgar","filing":"0001179110-21-000672","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000117911021000672/edgar.xml","form_type":"4"}},{"id":2904278,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-19T21:04:33.000Z","date":"2021-01-14","kind":"sale","acquired":false,"shares":164931,"price":225.12,"value":37129266.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average price of transactions ranging from $221.81 to $228.97. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":275793,"source":{"system":"sec-edgar","filing":"0001179110-21-000672","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000117911021000672/edgar.xml","form_type":"4"}},{"id":2904277,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-19T21:04:33.000Z","date":"2021-01-14","kind":"exercise","acquired":true,"shares":164931,"price":5.26,"value":867537.06,"ownership":{"direct":true},"balance_after":440724,"source":{"system":"sec-edgar","filing":"0001179110-21-000672","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000117911021000672/edgar.xml","form_type":"4"}},{"id":2971172,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-11-20T21:43:48.000Z","date":"2020-11-19","kind":"grant","acquired":true,"shares":1308,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of TDOC common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock unit vests in three substantially equal annual installments beginning November 19, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock unit vests in three substantially equal annual installments beginning November 19, 2021."}],"balance_after":1308,"derivative":{"underlying":"Common Stock","underlying_shares":1308},"source":{"system":"sec-edgar","filing":"0001179110-20-011269","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000117911020011269/edgar.xml","form_type":"4"}},{"id":2997371,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-10-30T17:15:48.000Z","date":"2020-10-30","kind":"disposition_to_issuer","acquired":false,"shares":166000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F19","text":"The \"Equity Award Adjustment Ratio\" means the quotient determined by dividing (i) the volume weighted average closing price of the Issuer's common stock on the four trading days ending on October 29, 2020 by (ii) the volume weighted average closing price of Teladoc common stock on the four trading days beginning on October 29, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F21","text":"Pursuant to the Merger Agreement, each outstanding stock option of the Issuer, whether vested or unvested, was converted into an option to purchase a number of shares of Teladoc common stock equal to the product of (i) the number of shares of the Issuer's common stock subject to such Issuer stock option immediately prior to the effective time of the merger and (ii) the Equity Award Adjustment Ratio (rounded down to the nearest whole share of Teladoc common stock on an award-by-award basis), with an exercise price equal to the quotient of (x) the exercise price of such Issuer stock option and (y) the Equity Award Adjustment Ratio (rounded up to the nearest whole cent), subject to the same terms and conditions as were applicable to such Issuer stock option immediately prior to the effective time of the merger (including applicable vesting conditions)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F24","text":"One-fourth of the shares subject to the option vested on June 19, 2019 and 1/48 of the shares vest monthly thereafter."}],"balance_after":0,"derivative":{"exercise_price":3.62,"expiration_date":"2028-06-18","underlying":"Common Stock","underlying_shares":166000},"source":{"system":"sec-edgar","filing":"0001639225-20-000060","document":"wf-form4_160409251194751.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000163922520000060/wf-form4_160409251194751.xml","form_type":"4"}},{"id":2997370,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-10-30T17:15:48.000Z","date":"2020-10-30","kind":"disposition_to_issuer","acquired":false,"shares":1040360,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F19","text":"The \"Equity Award Adjustment Ratio\" means the quotient determined by dividing (i) the volume weighted average closing price of the Issuer's common stock on the four trading days ending on October 29, 2020 by (ii) the volume weighted average closing price of Teladoc common stock on the four trading days beginning on October 29, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F21","text":"Pursuant to the Merger Agreement, each outstanding stock option of the Issuer, whether vested or unvested, was converted into an option to purchase a number of shares of Teladoc common stock equal to the product of (i) the number of shares of the Issuer's common stock subject to such Issuer stock option immediately prior to the effective time of the merger and (ii) the Equity Award Adjustment Ratio (rounded down to the nearest whole share of Teladoc common stock on an award-by-award basis), with an exercise price equal to the quotient of (x) the exercise price of such Issuer stock option and (y) the Equity Award Adjustment Ratio (rounded up to the nearest whole cent), subject to the same terms and conditions as were applicable to such Issuer stock option immediately prior to the effective time of the merger (including applicable vesting conditions)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F23","text":"One-fourth of the shares subject to the option vested on January 17, 2019 and 1/48 of the shares vest monthly thereafter."}],"balance_after":0,"derivative":{"exercise_price":3.62,"expiration_date":"2028-01-16","underlying":"Common Stock","underlying_shares":1040360},"source":{"system":"sec-edgar","filing":"0001639225-20-000060","document":"wf-form4_160409251194751.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000163922520000060/wf-form4_160409251194751.xml","form_type":"4"}},{"id":2997369,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-10-30T17:15:48.000Z","date":"2020-10-30","kind":"disposition_to_issuer","acquired":false,"shares":1294722,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F19","text":"The \"Equity Award Adjustment Ratio\" means the quotient determined by dividing (i) the volume weighted average closing price of the Issuer's common stock on the four trading days ending on October 29, 2020 by (ii) the volume weighted average closing price of Teladoc common stock on the four trading days beginning on October 29, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F21","text":"Pursuant to the Merger Agreement, each outstanding stock option of the Issuer, whether vested or unvested, was converted into an option to purchase a number of shares of Teladoc common stock equal to the product of (i) the number of shares of the Issuer's common stock subject to such Issuer stock option immediately prior to the effective time of the merger and (ii) the Equity Award Adjustment Ratio (rounded down to the nearest whole share of Teladoc common stock on an award-by-award basis), with an exercise price equal to the quotient of (x) the exercise price of such Issuer stock option and (y) the Equity Award Adjustment Ratio (rounded up to the nearest whole cent), subject to the same terms and conditions as were applicable to such Issuer stock option immediately prior to the effective time of the merger (including applicable vesting conditions)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F22","text":"One-fourth of the shares subject to the option vested on May 1, 2018 and 1/48 of the shares vest monthly thereafter."}],"balance_after":0,"derivative":{"exercise_price":1.88,"expiration_date":"2027-04-30","underlying":"Common Stock","underlying_shares":1294722},"source":{"system":"sec-edgar","filing":"0001639225-20-000060","document":"wf-form4_160409251194751.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000163922520000060/wf-form4_160409251194751.xml","form_type":"4"}},{"id":2997368,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-10-30T17:15:48.000Z","date":"2020-10-30","kind":"disposition_to_issuer","acquired":false,"shares":969169,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F19","text":"The \"Equity Award Adjustment Ratio\" means the quotient determined by dividing (i) the volume weighted average closing price of the Issuer's common stock on the four trading days ending on October 29, 2020 by (ii) the volume weighted average closing price of Teladoc common stock on the four trading days beginning on October 29, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F21","text":"Pursuant to the Merger Agreement, each outstanding stock option of the Issuer, whether vested or unvested, was converted into an option to purchase a number of shares of Teladoc common stock equal to the product of (i) the number of shares of the Issuer's common stock subject to such Issuer stock option immediately prior to the effective time of the merger and (ii) the Equity Award Adjustment Ratio (rounded down to the nearest whole share of Teladoc common stock on an award-by-award basis), with an exercise price equal to the quotient of (x) the exercise price of such Issuer stock option and (y) the Equity Award Adjustment Ratio (rounded up to the nearest whole cent), subject to the same terms and conditions as were applicable to such Issuer stock option immediately prior to the effective time of the merger (including applicable vesting conditions)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F20","text":"Shares subject to the option are fully vested and immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.8,"expiration_date":"2025-03-09","underlying":"Common Stock","underlying_shares":969169},"source":{"system":"sec-edgar","filing":"0001639225-20-000060","document":"wf-form4_160409251194751.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000163922520000060/wf-form4_160409251194751.xml","form_type":"4"}},{"id":2997367,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-10-30T17:15:48.000Z","date":"2020-10-30","kind":"disposition_to_issuer","acquired":false,"shares":297954,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F19","text":"The \"Equity Award Adjustment Ratio\" means the quotient determined by dividing (i) the volume weighted average closing price of the Issuer's common stock on the four trading days ending on October 29, 2020 by (ii) the volume weighted average closing price of Teladoc common stock on the four trading days beginning on October 29, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F21","text":"Pursuant to the Merger Agreement, each outstanding stock option of the Issuer, whether vested or unvested, was converted into an option to purchase a number of shares of Teladoc common stock equal to the product of (i) the number of shares of the Issuer's common stock subject to such Issuer stock option immediately prior to the effective time of the merger and (ii) the Equity Award Adjustment Ratio (rounded down to the nearest whole share of Teladoc common stock on an award-by-award basis), with an exercise price equal to the quotient of (x) the exercise price of such Issuer stock option and (y) the Equity Award Adjustment Ratio (rounded up to the nearest whole cent), subject to the same terms and conditions as were applicable to such Issuer stock option immediately prior to the effective time of the merger (including applicable vesting conditions)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F20","text":"Shares subject to the option are fully vested and immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.74,"expiration_date":"2024-02-12","underlying":"Common Stock","underlying_shares":297954},"source":{"system":"sec-edgar","filing":"0001639225-20-000060","document":"wf-form4_160409251194751.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000163922520000060/wf-form4_160409251194751.xml","form_type":"4"}},{"id":2997366,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-10-30T17:15:48.000Z","date":"2020-10-30","kind":"disposition_to_issuer","acquired":false,"shares":185121,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F17","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of August 5, 2020, by and among the Issuer, Teladoc Health, Inc. (\"Teladoc\"), and Tempranillo Merger Sub, Inc., a wholly owned subsidiary of Teladoc, each share of the Issuer's common stock was converted into the right to receive 0.5920 of a share of Teladoc common stock and $4.24 in cash, without interest, together with cash in lieu of fractional shares (if any)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by 7wire Management I, LLC. The reporting person serves as a Manager of 7wire Management, LLC, or 7wire Management, the Manager of 7wire Management I, LLC. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001639225-20-000060","document":"wf-form4_160409251194751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000163922520000060/wf-form4_160409251194751.xml","form_type":"4"}},{"id":2997365,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-10-30T17:15:48.000Z","date":"2020-10-30","kind":"disposition_to_issuer","acquired":false,"shares":35887,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F17","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of August 5, 2020, by and among the Issuer, Teladoc Health, Inc. (\"Teladoc\"), and Tempranillo Merger Sub, Inc., a wholly owned subsidiary of Teladoc, each share of the Issuer's common stock was converted into the right to receive 0.5920 of a share of Teladoc common stock and $4.24 in cash, without interest, together with cash in lieu of fractional shares (if any)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"The shares are held of record by 7wire Ventures Fund, L.P. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures Fund, L.P. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001639225-20-000060","document":"wf-form4_160409251194751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000163922520000060/wf-form4_160409251194751.xml","form_type":"4"}},{"id":2997364,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-10-30T17:15:48.000Z","date":"2020-10-30","kind":"disposition_to_issuer","acquired":false,"shares":992679,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F16","text":"Includes 77,652 restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F17","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of August 5, 2020, by and among the Issuer, Teladoc Health, Inc. (\"Teladoc\"), and Tempranillo Merger Sub, Inc., a wholly owned subsidiary of Teladoc, each share of the Issuer's common stock was converted into the right to receive 0.5920 of a share of Teladoc common stock and $4.24 in cash, without interest, together with cash in lieu of fractional shares (if any)."},{"field":"price","element":"transactionPricePerShare","label":"F18","text":"Pursuant to the Merger Agreement, each outstanding RSU award of the Issuer was converted into a number of RSUs with respect to a number of shares of Teladoc common stock equal to the product of (i) the number of shares of the Issuer's common stock subject to such RSU award immediately prior to the effective time of the merger and (ii) the Equity Award Adjustment Ratio (as defined below) (rounded down to the nearest whole share of Teladoc common stock on an award-by-award basis), subject to the same terms and conditions as were applicable to such Issuer RSU immediately prior to the effective time of the merger (including applicable vesting conditions)."},{"field":"price","element":"transactionPricePerShare","label":"F19","text":"The \"Equity Award Adjustment Ratio\" means the quotient determined by dividing (i) the volume weighted average closing price of the Issuer's common stock on the four trading days ending on October 29, 2020 by (ii) the volume weighted average closing price of Teladoc common stock on the four trading days beginning on October 29, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001639225-20-000060","document":"wf-form4_160409251194751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000163922520000060/wf-form4_160409251194751.xml","form_type":"4"}},{"id":2997363,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-10-30T17:15:48.000Z","date":"2020-10-30","kind":"other","acquired":true,"shares":173041,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F15","text":"Represents the receipt of shares pursuant to pro rata in-kind distributions by 7wire Ventures Fund L.P. and 7wire Ventures Wanxiang Strategic Fund I, LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by 7wire Management I, LLC. The reporting person serves as a Manager of 7wire Management, LLC, or 7wire Management, the Manager of 7wire Management I, LLC. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":185121,"source":{"system":"sec-edgar","filing":"0001639225-20-000060","document":"wf-form4_160409251194751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000163922520000060/wf-form4_160409251194751.xml","form_type":"4"}},{"id":2997362,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-10-30T17:15:48.000Z","date":"2020-10-30","kind":"other","acquired":true,"shares":27105,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F14","text":"Represents the receipt of shares pursuant to a pro rata in-kind distribution by 7wire Ventures Fund L.P."}],"balance_after":992679,"source":{"system":"sec-edgar","filing":"0001639225-20-000060","document":"wf-form4_160409251194751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000163922520000060/wf-form4_160409251194751.xml","form_type":"4"}},{"id":2997361,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-10-30T17:15:48.000Z","date":"2020-10-30","kind":"other","acquired":false,"shares":940788,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F12","text":"Represents a pro rata in-kind distribution by 7wire Ventures Fund, L.P. without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"The shares are held of record by 7wire Ventures Fund, L.P. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures Fund, L.P. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":35887,"source":{"system":"sec-edgar","filing":"0001639225-20-000060","document":"wf-form4_160409251194751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000163922520000060/wf-form4_160409251194751.xml","form_type":"4"}},{"id":2997360,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-10-30T17:15:48.000Z","date":"2020-10-29","kind":"other","acquired":true,"shares":37712,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"Represents the receipt of shares pursuant to pro rata in-kind distributions by 7wire Ventures LLC - Series Livongo D and 7wire Ventures LLC - Series Livongo E."}],"balance_after":965574,"source":{"system":"sec-edgar","filing":"0001639225-20-000060","document":"wf-form4_160409251194751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000163922520000060/wf-form4_160409251194751.xml","form_type":"4"}},{"id":2997359,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-10-30T17:15:48.000Z","date":"2020-10-29","kind":"other","acquired":false,"shares":195277,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Represents a pro rata in-kind distribution by 7wire Ventures LLC - Series Livongo E without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The shares were held of record by 7wire Ventures LLC - Series Livongo E. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC - Series Livongo E. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001639225-20-000060","document":"wf-form4_160409251194751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000163922520000060/wf-form4_160409251194751.xml","form_type":"4"}},{"id":2997358,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-10-30T17:15:48.000Z","date":"2020-10-29","kind":"other","acquired":false,"shares":176361,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Represents a pro rata in-kind distribution by 7wire Ventures LLC - Series Livongo D without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"The shares were held of record by 7wire Ventures LLC - Series Livongo D. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC - Series Livongo D. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001639225-20-000060","document":"wf-form4_160409251194751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000163922520000060/wf-form4_160409251194751.xml","form_type":"4"}},{"id":2997357,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-10-30T17:15:48.000Z","date":"2020-10-29","kind":"other","acquired":false,"shares":109748,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro rata in-kind distribution by 7wire Ventures LLC - Series Livongo C without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares were held of record by 7wire Ventures LLC - Series Livongo C. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC - Series Livongo C. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001639225-20-000060","document":"wf-form4_160409251194751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000163922520000060/wf-form4_160409251194751.xml","form_type":"4"}},{"id":2997356,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-10-30T17:15:48.000Z","date":"2020-10-29","kind":"other","acquired":false,"shares":1185097,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro rata in-kind distribution by 7wire Ventures, LLC - Series EosHealth without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares were held of record by 7wire Ventures LLC - Series EosHealth. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC - Series EosHealth. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001639225-20-000060","document":"wf-form4_160409251194751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000163922520000060/wf-form4_160409251194751.xml","form_type":"4"}},{"id":2997355,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-10-30T17:15:48.000Z","date":"2020-09-11","kind":"other","acquired":true,"shares":12080,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the receipt of shares pursuant to a pro rata in-kind distribution by 7wire Ventures Wanxiang Strategic Fund I, LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by 7wire Management I, LLC. The reporting person serves as a Manager of 7wire Management, LLC, or 7wire Management, the Manager of 7wire Management I, LLC. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":12080,"source":{"system":"sec-edgar","filing":"0001639225-20-000060","document":"wf-form4_160409251194751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000163922520000060/wf-form4_160409251194751.xml","form_type":"4"}},{"id":2997354,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-10-30T17:15:48.000Z","date":"2020-05-05","kind":"gift","acquired":false,"shares":19941,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":927862,"source":{"system":"sec-edgar","filing":"0001639225-20-000060","document":"wf-form4_160409251194751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000163922520000060/wf-form4_160409251194751.xml","form_type":"4"}},{"id":3029879,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-09-16T18:10:28.000Z","date":"2020-09-14","kind":"sale","acquired":false,"shares":23,"price":124.4602,"value":2862.5846,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.46 to $124.465, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by 7wire Ventures Fund, L.P., or 7wire LP. The reporting person serves as a Manager of 7wire Management, LLC, or 7wire Management, the Manager of 7wire LP. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":976675,"source":{"system":"sec-edgar","filing":"0001209191-20-050760","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000120919120050760/doc4.xml","form_type":"4"}},{"id":3031144,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-09-15T16:50:18.000Z","date":"2020-09-11","kind":"other","acquired":true,"shares":21604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"Represents the receipt of shares pursuant to pro rata in-kind distributions by 7wire LP, 7wire Ventures, LLC - Series Livongo D and 7wire Ventures, LLC - Series Livongo E."}],"balance_after":947803,"source":{"system":"sec-edgar","filing":"0001209191-20-050485","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000120919120050485/doc4.xml","form_type":"4"}},{"id":3031143,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-09-15T16:50:18.000Z","date":"2020-09-11","kind":"other","acquired":false,"shares":65081,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Represents a pro rata in-kind distribution by 7wire Ventures LLC - Series Livongo E without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The shares are held of record by 7wire Ventures LLC - Series Livongo E. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC - Series Livongo E. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":195277,"source":{"system":"sec-edgar","filing":"0001209191-20-050485","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000120919120050485/doc4.xml","form_type":"4"}},{"id":3031142,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-09-15T16:50:18.000Z","date":"2020-09-11","kind":"other","acquired":false,"shares":58773,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Represents a pro rata in-kind distribution by 7wire Ventures LLC - Series Livongo D without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"The shares are held of record by 7wire Ventures LLC - Series Livongo D. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC - Series Livongo D. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":176361,"source":{"system":"sec-edgar","filing":"0001209191-20-050485","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000120919120050485/doc4.xml","form_type":"4"}},{"id":3031141,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-09-15T16:50:18.000Z","date":"2020-09-11","kind":"other","acquired":false,"shares":36576,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro rata in-kind distribution by 7wire Ventures LLC - Series Livongo C without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held of record by 7wire Ventures LLC - Series Livongo C. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC - Series Livongo C. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":109748,"source":{"system":"sec-edgar","filing":"0001209191-20-050485","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000120919120050485/doc4.xml","form_type":"4"}},{"id":3031140,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-09-15T16:50:18.000Z","date":"2020-09-11","kind":"other","acquired":false,"shares":395025,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro rata in-kind distribution by 7wire Ventures, LLC - Series EosHealth without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by 7wire Ventures LLC-Series EosHealth. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC-Series EosHealth. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":1185097,"source":{"system":"sec-edgar","filing":"0001209191-20-050485","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000120919120050485/doc4.xml","form_type":"4"}},{"id":3031139,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-09-15T16:50:18.000Z","date":"2020-09-11","kind":"other","acquired":false,"shares":312511,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata in-kind distribution by 7wire Ventures Fund, L.P., or 7wire LP, without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by 7wire LP. The reporting person serves as a Manager of 7wire Management, LLC, or 7wire Management, the Manager of 7wire LP. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":976698,"source":{"system":"sec-edgar","filing":"0001209191-20-050485","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000120919120050485/doc4.xml","form_type":"4"}},{"id":3037385,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-09-04T21:02:15.000Z","date":"2020-09-03","kind":"exercise","acquired":false,"shares":422000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Shares subject to the option are fully vested and immediately exercisable."}],"balance_after":297954,"derivative":{"exercise_price":0.74,"expiration_date":"2024-02-12","underlying":"Common Stock","underlying_shares":422000},"source":{"system":"sec-edgar","filing":"0001209191-20-049674","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000120919120049674/doc4.xml","form_type":"4"}},{"id":3037384,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-09-04T21:02:15.000Z","date":"2020-09-03","kind":"sale","acquired":false,"shares":422000,"price":124.5,"value":52539000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 5, 2020, the Issuer entered into an Agreement and Plan of Merger with Teladoc Health, Inc. (\"Teladoc\") and Tempranillo Merger Sub, Inc., a wholly-owned subsidiary of Teladoc (\"Merger Sub\"), pursuant to which Merger Sub will merge with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Teladoc (the \"Merger\"). Pursuant to the terms of the Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2019, as amended and restated (the \"Trading Plan\"), all sales pursuant to the Trading Plan were automatically suspended following the public announcement of the Merger without any action by the reporting person, and the Trading Plan was subsequently terminated. The number of shares sold and reported on this form is consistent with the number of shares that would have been sold by the reporting person pursuant to the Trading Plan had the Trading Plan not been suspended in connection with the Merger."},{"field":"kind","element":"transactionCoding","label":"F2","text":"In addition, in connection with the Merger the reporting person entered into a voting agreement with Teladoc and certain other stockholders of the Issuer party thereto (the \"Voting Agreement\"), pursuant to which, subject to certain exceptions, the reporting person agreed to vote all shares of the Issuer's common stock held by the reporting person in favor of the approval of the Merger. The sales reported on this form are expressly permitted and contemplated by the Voting Agreement, which permits the reporting person to sell or transfer a number of shares of the Issuer's common stock equivalent to such number of shares that would have been sold had the Trading Plan remained in effect. Following the sales reported on this form, the reporting person continues to hold over 85% of the shares of the Issuer's common stock and vested stock options directly held immediately prior to such sales."}],"balance_after":926199,"source":{"system":"sec-edgar","filing":"0001209191-20-049674","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000120919120049674/doc4.xml","form_type":"4"}},{"id":3037383,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-09-04T21:02:15.000Z","date":"2020-09-03","kind":"exercise","acquired":true,"shares":422000,"price":0.74,"value":312280.0,"ownership":{"direct":true},"balance_after":1348199,"source":{"system":"sec-edgar","filing":"0001209191-20-049674","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000120919120049674/doc4.xml","form_type":"4"}},{"id":3044468,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-08-28T16:04:09.000Z","date":"2020-08-26","kind":"sale","acquired":false,"shares":2322,"price":132.53,"value":307734.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."}],"balance_after":926199,"source":{"system":"sec-edgar","filing":"0001209191-20-048605","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000120919120048605/doc4.xml","form_type":"4"}},{"id":3094986,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-07-01T19:31:07.000Z","date":"2020-06-30","kind":"sale","acquired":false,"shares":52,"price":74.76,"value":3887.52,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held of record by 7wire Ventures Fund, L.P., or 7wire LP. The reporting person serves as a Manager of 7wire Management, LLC, or 7wire Management, the Manager of 7wire LP. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":1289209,"source":{"system":"sec-edgar","filing":"0001209191-20-039943","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000120919120039943/doc4.xml","form_type":"4"}},{"id":3097453,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-06-29T21:52:04.000Z","date":"2020-06-25","kind":"other","acquired":true,"shares":26589,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"Represents the receipt of shares pursuant to pro rata in-kind distributions by 7wire LP, 7wire Ventures, LLC - Series Livongo D and 7wire Ventures, LLC - Series Livongo E."}],"balance_after":928521,"source":{"system":"sec-edgar","filing":"0000899243-20-017830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000089924320017830/doc4.xml","form_type":"4"}},{"id":3097452,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-06-29T21:52:04.000Z","date":"2020-06-25","kind":"other","acquired":false,"shares":384629,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Represents a pro rata in-kind distribution by 7wire Ventures Fund, L.P., or 7wire LP, without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The shares are held of record by 7wire LP. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire LP. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":1289261,"source":{"system":"sec-edgar","filing":"0000899243-20-017830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000089924320017830/doc4.xml","form_type":"4"}},{"id":3097451,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-06-29T21:52:04.000Z","date":"2020-06-25","kind":"other","acquired":false,"shares":80099,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Represents a pro rata in-kind distribution by 7wire Ventures LLC - Series Livongo E without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"The shares are held of record by 7wire Ventures LLC - Series Livongo E. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC - Series Livongo E. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":260358,"source":{"system":"sec-edgar","filing":"0000899243-20-017830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000089924320017830/doc4.xml","form_type":"4"}},{"id":3097450,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-06-29T21:52:04.000Z","date":"2020-06-25","kind":"other","acquired":false,"shares":72337,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro rata in-kind distribution by 7wire Ventures LLC - Series Livongo D without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held of record by 7wire Ventures LLC - Series Livongo D. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC - Series Livongo D. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":235134,"source":{"system":"sec-edgar","filing":"0000899243-20-017830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000089924320017830/doc4.xml","form_type":"4"}},{"id":3097449,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-06-29T21:52:04.000Z","date":"2020-06-25","kind":"other","acquired":false,"shares":45017,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro rata in-kind distribution by 7wire Ventures LLC - Series Livongo C without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by 7wire Ventures LLC - Series Livongo C. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC - Series Livongo C. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":146324,"source":{"system":"sec-edgar","filing":"0000899243-20-017830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000089924320017830/doc4.xml","form_type":"4"}},{"id":3097448,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-06-29T21:52:04.000Z","date":"2020-06-25","kind":"other","acquired":false,"shares":486183,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata in-kind distribution by 7wire Ventures, LLC - Series EosHealth without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by 7wire Ventures LLC-Series EosHealth. The reporting person serves as a Manager of 7wire Management, LLC, or 7wire Management, the Manager of 7wire Ventures LLC-Series EosHealth. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":1580122,"source":{"system":"sec-edgar","filing":"0000899243-20-017830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000089924320017830/doc4.xml","form_type":"4"}},{"id":3131906,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-05-28T17:52:07.000Z","date":"2020-05-26","kind":"exercise","acquired":false,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2019, as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"Shares subject to the option are fully vested and immediately exercisable."}],"balance_after":719954,"derivative":{"exercise_price":0.74,"expiration_date":"2024-02-12","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001209191-20-032683","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000120919120032683/doc4.xml","form_type":"4"}},{"id":3131905,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-05-28T17:52:07.000Z","date":"2020-05-26","kind":"sale","acquired":false,"shares":13175,"price":60.2735,"value":794103.3625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2019, as amended and restated."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.15 to $61.11, inclusive."}],"balance_after":901932,"source":{"system":"sec-edgar","filing":"0001209191-20-032683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000120919120032683/doc4.xml","form_type":"4"}},{"id":3131904,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-05-28T17:52:07.000Z","date":"2020-05-26","kind":"sale","acquired":false,"shares":26629,"price":59.5514,"value":1585794.2306,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2019, as amended and restated."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.14 to $60.13, inclusive."}],"balance_after":915107,"source":{"system":"sec-edgar","filing":"0001209191-20-032683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000120919120032683/doc4.xml","form_type":"4"}},{"id":3131903,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-05-28T17:52:07.000Z","date":"2020-05-26","kind":"sale","acquired":false,"shares":30109,"price":58.7893,"value":1770087.0337,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2019, as amended and restated."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.12 to $59.10, inclusive."}],"balance_after":941736,"source":{"system":"sec-edgar","filing":"0001209191-20-032683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000120919120032683/doc4.xml","form_type":"4"}},{"id":3131902,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-05-28T17:52:07.000Z","date":"2020-05-26","kind":"sale","acquired":false,"shares":45040,"price":57.6811,"value":2597956.744,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2019, as amended and restated."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.11 to $58.10, inclusive."}],"balance_after":971845,"source":{"system":"sec-edgar","filing":"0001209191-20-032683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000120919120032683/doc4.xml","form_type":"4"}},{"id":3131901,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-05-28T17:52:07.000Z","date":"2020-05-26","kind":"sale","acquired":false,"shares":10093,"price":56.6098,"value":571362.7114,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2019, as amended and restated."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.10 to $56.97, inclusive."}],"balance_after":1016885,"source":{"system":"sec-edgar","filing":"0001209191-20-032683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000120919120032683/doc4.xml","form_type":"4"}},{"id":3131900,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-05-28T17:52:07.000Z","date":"2020-05-26","kind":"sale","acquired":false,"shares":40954,"price":54.4771,"value":2231055.1534,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2019, as amended and restated."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.10 to $55.00, inclusive."}],"balance_after":1026978,"source":{"system":"sec-edgar","filing":"0001209191-20-032683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000120919120032683/doc4.xml","form_type":"4"}},{"id":3131899,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-05-28T17:52:07.000Z","date":"2020-05-26","kind":"sale","acquired":false,"shares":4000,"price":53.6133,"value":214453.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2019, as amended and restated."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.09 to $54.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (8) to this Form 4."}],"balance_after":1067932,"source":{"system":"sec-edgar","filing":"0001209191-20-032683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000120919120032683/doc4.xml","form_type":"4"}},{"id":3131898,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-05-28T17:52:07.000Z","date":"2020-05-26","kind":"exercise","acquired":true,"shares":170000,"price":0.74,"value":125800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2019, as amended and restated."}],"balance_after":1071932,"source":{"system":"sec-edgar","filing":"0001209191-20-032683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000120919120032683/doc4.xml","form_type":"4"}},{"id":3145139,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-05-18T18:41:53.000Z","date":"2020-05-14","kind":"grant","acquired":true,"shares":82828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units which vest in 16 equal quarterly installments beginning on August 25, 2020."}],"balance_after":901932,"source":{"system":"sec-edgar","filing":"0001209191-20-030223","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000120919120030223/doc4.xml","form_type":"4"}},{"id":3177774,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-04-13T19:18:56.000Z","date":"2020-04-09","kind":"other","acquired":true,"shares":19941,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F12","text":"Represents the receipt of shares pursuant to pro rata in-kind distributions by 7wire LP, 7wire Ventures, LLC - Series Livongo D and 7wire Ventures, LLC - Series Livongo E."}],"balance_after":819104,"source":{"system":"sec-edgar","filing":"0000899243-20-010677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000089924320010677/doc4.xml","form_type":"4"}},{"id":3177773,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-04-13T19:18:56.000Z","date":"2020-04-09","kind":"other","acquired":false,"shares":288469,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"Represents a pro rata in-kind distribution by 7wire LP without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The shares are held of record by 7wire LP. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire LP. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":1673890,"source":{"system":"sec-edgar","filing":"0000899243-20-010677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000089924320010677/doc4.xml","form_type":"4"}},{"id":3177772,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-04-13T19:18:56.000Z","date":"2020-04-09","kind":"other","acquired":true,"shares":802458,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Represents the receipt of shares by 7wire LP pursuant to pro rata in-kind distributions by 7wire Ventures, LLC - Series EosHealth and 7wire Ventures LLC - Series Livongo C without consideration to its partners (including 7wire LP)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The shares are held of record by 7wire LP. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire LP. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":1962359,"source":{"system":"sec-edgar","filing":"0000899243-20-010677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000089924320010677/doc4.xml","form_type":"4"}},{"id":3177771,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-04-13T19:18:56.000Z","date":"2020-04-09","kind":"other","acquired":false,"shares":60071,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Represents a pro rata in-kind distribution by 7wire Ventures LLC - Series Livongo E without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"The shares are held of record by 7wire Ventures LLC - Series Livongo E. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC - Series Livongo E. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":340457,"source":{"system":"sec-edgar","filing":"0000899243-20-010677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000089924320010677/doc4.xml","form_type":"4"}},{"id":3177770,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-04-13T19:18:56.000Z","date":"2020-04-09","kind":"other","acquired":false,"shares":54247,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro rata in-kind distribution by 7wire Ventures LLC - Series Livongo D without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held of record by 7wire Ventures LLC - Series Livongo D. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC - Series Livongo D. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":307471,"source":{"system":"sec-edgar","filing":"0000899243-20-010677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000089924320010677/doc4.xml","form_type":"4"}},{"id":3177769,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-04-13T19:18:56.000Z","date":"2020-04-09","kind":"other","acquired":false,"shares":93790,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro rata in-kind distribution by 7wire Ventures LLC - Series Livongo C without consideration to its partners (including 7wire LP)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by 7wire Ventures LLC - Series Livongo C. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC - Series Livongo C. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":191341,"source":{"system":"sec-edgar","filing":"0000899243-20-010677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000089924320010677/doc4.xml","form_type":"4"}},{"id":3177768,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-04-13T19:18:56.000Z","date":"2020-04-09","kind":"other","acquired":false,"shares":1307682,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata in-kind distribution by 7wire Ventures, LLC - Series EosHealth without consideration to its partners (including 7wire Ventures Fund, L.P., or 7wire LP)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by 7wire Ventures LLC-Series EosHealth. The reporting person serves as a Manager of 7wire Management, LLC, or 7wire Management, the Manager of 7wire Ventures LLC-Series EosHealth. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":2066305,"source":{"system":"sec-edgar","filing":"0000899243-20-010677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000089924320010677/doc4.xml","form_type":"4"}},{"id":3200385,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-03-19T16:18:32.000Z","date":"2020-03-17","kind":"exercise","acquired":false,"shares":50096,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Shares subject to the option are fully vested and immediately exercisable."}],"balance_after":889954,"derivative":{"exercise_price":0.74,"expiration_date":"2024-02-12","underlying":"Common Stock","underlying_shares":50096},"source":{"system":"sec-edgar","filing":"0001209191-20-020264","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000120919120020264/doc4.xml","form_type":"4"}},{"id":3200384,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-03-19T16:18:32.000Z","date":"2020-03-17","kind":"exercise","acquired":false,"shares":119904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Shares subject to the option are fully vested and immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.36,"expiration_date":"2024-06-01","underlying":"Common Stock","underlying_shares":119904},"source":{"system":"sec-edgar","filing":"0001209191-20-020264","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000120919120020264/doc4.xml","form_type":"4"}},{"id":3200383,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-03-19T16:18:32.000Z","date":"2020-03-17","kind":"sale","acquired":false,"shares":54368,"price":22.0154,"value":1196933.2672,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.11, inclusive."}],"balance_after":799163,"source":{"system":"sec-edgar","filing":"0001209191-20-020264","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000120919120020264/doc4.xml","form_type":"4"}},{"id":3200382,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-03-19T16:18:32.000Z","date":"2020-03-17","kind":"sale","acquired":false,"shares":45023,"price":21.1953,"value":954275.9919,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.98, inclusive."}],"balance_after":853531,"source":{"system":"sec-edgar","filing":"0001209191-20-020264","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000120919120020264/doc4.xml","form_type":"4"}},{"id":3200381,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-03-19T16:18:32.000Z","date":"2020-03-17","kind":"sale","acquired":false,"shares":70609,"price":20.5528,"value":1451212.6552,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4."}],"balance_after":898554,"source":{"system":"sec-edgar","filing":"0001209191-20-020264","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000120919120020264/doc4.xml","form_type":"4"}},{"id":3200380,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-03-19T16:18:32.000Z","date":"2020-03-17","kind":"exercise","acquired":true,"shares":50096,"price":0.74,"value":37071.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2019."}],"balance_after":969163,"source":{"system":"sec-edgar","filing":"0001209191-20-020264","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000120919120020264/doc4.xml","form_type":"4"}},{"id":3200379,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-03-19T16:18:32.000Z","date":"2020-03-17","kind":"exercise","acquired":true,"shares":119904,"price":0.36,"value":43165.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2019."}],"balance_after":919067,"source":{"system":"sec-edgar","filing":"0001209191-20-020264","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000120919120020264/doc4.xml","form_type":"4"}},{"id":3453079,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Series E Convertible Preferred Stock","published_at":"2019-07-30T16:29:27.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":60000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The shares are held of record by 7Wire Ventures Wanxiang Strategic Fund I, LLC, or 7Wire Wanxiang. The reporting person serves as a Manager of 7Wire Management, the Manager of 7Wire Wanxiang. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-19-020579","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000089924319020579/doc4.xml","form_type":"4"}},{"id":3453078,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Series E Convertible Preferred Stock","published_at":"2019-07-30T16:29:27.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":400528,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"The shares are held of record by 7Wire Ventures LLC - Series Livongo E. The reporting person serves as a Manager of 7Wire Management, the Manager of 7Wire Ventures LLC - Series Livongo E. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":400528},"source":{"system":"sec-edgar","filing":"0000899243-19-020579","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000089924319020579/doc4.xml","form_type":"4"}},{"id":3453077,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Series E Convertible Preferred Stock","published_at":"2019-07-30T16:29:27.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":488683,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by 7Wire Ventures Fund, L.P., or 7Wire LP. The reporting person serves as a Manager of 7Wire Management, LLC, or 7Wire Management, the Manager of 7Wire LP. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":488683},"source":{"system":"sec-edgar","filing":"0000899243-19-020579","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000089924319020579/doc4.xml","form_type":"4"}},{"id":3453076,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Series D Convertible Preferred Stock","published_at":"2019-07-30T16:29:27.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":361718,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held of record by 7Wire Ventures LLC - Series Livongo D. The reporting person serves as a Manager of 7Wire Management, the Manager of 7Wire Ventures LLC - Series Livongo D. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":361718},"source":{"system":"sec-edgar","filing":"0000899243-19-020579","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000089924319020579/doc4.xml","form_type":"4"}},{"id":3453075,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Series D Convertible Preferred Stock","published_at":"2019-07-30T16:29:27.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":250080,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by 7Wire Ventures Fund, L.P., or 7Wire LP. The reporting person serves as a Manager of 7Wire Management, LLC, or 7Wire Management, the Manager of 7Wire LP. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":250080},"source":{"system":"sec-edgar","filing":"0000899243-19-020579","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000089924319020579/doc4.xml","form_type":"4"}},{"id":3453074,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Series C Convertible Preferred Stock","published_at":"2019-07-30T16:29:27.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":285131,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by 7Wire Ventures LLC - Series Livongo C. The reporting person serves as a Manager of 7Wire Management, the Manager of 7Wire Ventures LLC - Series Livongo C. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":285131},"source":{"system":"sec-edgar","filing":"0000899243-19-020579","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000089924319020579/doc4.xml","form_type":"4"}},{"id":3453073,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Series C Convertible Preferred Stock","published_at":"2019-07-30T16:29:27.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":2104,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by 7Wire Ventures Fund, L.P., or 7Wire LP. The reporting person serves as a Manager of 7Wire Management, LLC, or 7Wire Management, the Manager of 7Wire LP. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2104},"source":{"system":"sec-edgar","filing":"0000899243-19-020579","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000089924319020579/doc4.xml","form_type":"4"}},{"id":3453072,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Series A Convertible Preferred Stock","published_at":"2019-07-30T16:29:27.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":3506,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by 7Wire Ventures Fund, L.P., or 7Wire LP. The reporting person serves as a Manager of 7Wire Management, LLC, or 7Wire Management, the Manager of 7Wire LP. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3506},"source":{"system":"sec-edgar","filing":"0000899243-19-020579","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000089924319020579/doc4.xml","form_type":"4"}},{"id":3453071,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2019-07-30T16:29:27.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":60000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The shares are held of record by 7Wire Ventures Wanxiang Strategic Fund I, LLC, or 7Wire Wanxiang. The reporting person serves as a Manager of 7Wire Management, the Manager of 7Wire Wanxiang. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":60000,"source":{"system":"sec-edgar","filing":"0000899243-19-020579","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000089924319020579/doc4.xml","form_type":"4"}},{"id":3453070,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2019-07-30T16:29:27.000Z","date":"2019-07-29","kind":"exercise","acquired":true,"shares":400528,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"The shares are held of record by 7Wire Ventures LLC - Series Livongo E. The reporting person serves as a Manager of 7Wire Management, the Manager of 7Wire Ventures LLC - Series Livongo E. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":400528,"source":{"system":"sec-edgar","filing":"0000899243-19-020579","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000089924319020579/doc4.xml","form_type":"4"}},{"id":3453069,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2019-07-30T16:29:27.000Z","date":"2019-07-29","kind":"exercise","acquired":true,"shares":361718,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held of record by 7Wire Ventures LLC - Series Livongo D. The reporting person serves as a Manager of 7Wire Management, the Manager of 7Wire Ventures LLC - Series Livongo D. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":361718,"source":{"system":"sec-edgar","filing":"0000899243-19-020579","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000089924319020579/doc4.xml","form_type":"4"}},{"id":3453068,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2019-07-30T16:29:27.000Z","date":"2019-07-29","kind":"exercise","acquired":true,"shares":285131,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by 7Wire Ventures LLC - Series Livongo C. The reporting person serves as a Manager of 7Wire Management, the Manager of 7Wire Ventures LLC - Series Livongo C. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":285131,"source":{"system":"sec-edgar","filing":"0000899243-19-020579","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000089924319020579/doc4.xml","form_type":"4"}},{"id":3453067,"issuer":{"id":145566,"kind":"organization","name":"Livongo Health, Inc.","symbol":"LVGO"},"owners":[{"id":140602,"kind":"person","name":"TULLMAN GLEN","position":1,"cik":"0001213349","reported_name":"TULLMAN GLEN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2019-07-30T16:29:27.000Z","date":"2019-07-29","kind":"exercise","acquired":true,"shares":745093,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by 7Wire Ventures Fund, L.P., or 7Wire LP. The reporting person serves as a Manager of 7Wire Management, LLC, or 7Wire Management, the Manager of 7Wire LP. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":1159901,"source":{"system":"sec-edgar","filing":"0000899243-19-020579","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213349/000089924319020579/doc4.xml","form_type":"4"}}]}